Abstract
Background In response to the coronavirus diseases 2019 (COVID-19) pandemic, the Japanese government declared a state of emergency on April 7, 2020. Six days earlier, the Japan Surgical Society had recommended postponing elective surgical procedures. Along with the growing public fear of COVID-19, hospital visits in Japan decreased.
Methods Using claims data from the Quality Indicator/Improvement Project (QIP) database, this study aimed to clarify the impact of the first wave of the pandemic, considered to be from March to May 2020, on case volume and claimed hospital charges in acute care hospitals during this period. To make year-over-year comparisons, we considered cases from July 2018 to June 2020.
Results A total of 2,739,878 inpatient and 53,479,658 outpatient cases from 195 hospitals were included. In the year-over-year comparisons, total claimed hospital charges decreased in April, May, June 2020 by 7%, 14%, and 5%, respectively, compared to the same months in 2019. Our results also showed that per-case hospital charges increased during this period, possibly to compensate for the reduced case volumes. Regression results indicated that the hospital charges in April and May 2020 decreased by 6.3% for hospitals without COVID-19 patients. For hospitals with COVID-19 patients, there was an additional decrease in proportion with the length of hospital stay of COVID-19 patients including suspected cases. The mean additional decrease per COVID-19 patients was estimated to 5.5 million JPY.
Conclusion It is suggested that the hospitals treating COVID-19 patients were negatively incentivized.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by JSPS KAKENHI Grant Numbers JP19H01075 from the Japan Society for the Promotion of Science, Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, Japan, Grant Numbers 20HA2003, and by GAP Fund Program of Kyoto University, type B (2020) to Yuichi Imanaka. The funders played no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was conducted in accordance with the Ethical Guidelines for Medical and Health Research Involving Human Subjects of the Ministry of Health, Labour and Welfare, Japan. The Ethics Committee, Graduate School of Medicine, Kyoto University approved the study (approval number: R0135).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
E-mail: shin.jungho.76v{at}st.kyoto-u.ac.jp, takada.daisuke.76a{at}st.kyoto-u.ac.jp, morishita.tetsuji.42z{at}st.kyoto-u.ac.jp, lin.hueiru.72c{at}st.kyoto-u.ac.jp, bun.seiko.58w{at}st.kyoto-u.ac.jp, teraoka.emi.57m{at}st.kyoto-u.ac.jp, okuno.takuya.54e{at}st.kyoto-u.ac.jp, itoshima.hisashi.48a{at}st.kyoto-u.ac.jp, nagano0408{at}gmail.com, kenji123kishimoto223{at}gmail.com, hirotanhabatan{at}gmail.com, asami.yuka.73m{at}st.kyoto-u.ac.jp, higuchi.takuya.58c{at}st.kyoto-u.ac.jp, j.marquez9363060{at}gmail.com, kunisawa.susumu.2v{at}kyoto-u.ac.jp, imanaka-y{at}umin.net
Funding Statement updated; Table 2 revised; Supplemental files updated.
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
